MIL OSI Translation. Region: Russian Federation –
April 21, 2021 8:01 am
Photo by Y. Ivanko. Mos.ru
Research into the use of plasma from vaccinated donors began in Moscow in March. After its completion, a final decision will be made whether it is possible to invite vaccinated Muscovites to become plasma donors.
In Moscow, 120 people took part in a study of the effectiveness of plasma obtained from donors. They were divided into two groups: the first received plasma transfusions from donors who recovered from COVID-19, and the second from those vaccinated. This was reported by the press service of the capital’s social development complex.
“Research on the use of plasma from donors vaccinated against COVID-19 continues in Moscow. During the month 120 people took part in it. 63 patients in the experimental group received plasma transfusions from vaccinated donors, while participants in the control group received plasma transfusions from those who had been ill. Some patients continue to be under the supervision of doctors in hospitals, and some have already been discharged. The city uses the services of a single digital platform, which have already proven themselves during the pandemic: discharges are monitored through telemedicine. The researchers also reported that there were no complications from the transfusion in the recipients. Since the study is blind, we will know the final results about the effectiveness of plasma from vaccinated donors only after its completion, ”said the press service of the complex.
In March, the capital began to study the use of donor plasma with antibodies to coronavirus infection, obtained from donors after vaccination against the disease. After the study is completed, clinics will finally decide whether it is possible to invite vaccinated Muscovites to become plasma donors, and formulate selection criteria.
Plasma transfusion from people who recovered from the coronavirus began to be used in city hospitals in April 2020. During this time, 20 thousand people became donors. They donated over 13 tons of plasma.
Plasma is used in all hospitals in the city to treat patients with moderate and severe coronavirus infection. Plasma transfusion is included in the Moscow clinical protocol for the treatment of patients with a new coronavirus infection (COVID-19) and is used in a complex of therapy. Plasma contains specific antibodies that help neutralize the virus.
Detailed information for plasma donors after a previous coronavirus infection is available at website Moscow Department of Health.
EDITOR’S NOTE: This article is a translation. Apologies should the grammar and or sentence structure not be perfect.